Adjuvant chemotherapy to improve survival in average-risk adult medulloblastoma patients: Long-term results.

2037Background: Medulloblastoma is extremely rare in adults and, therefore, it is difficult to accrual patients in clinical trials. Radical surgery and radiotherapy (RT) provide a significant contr...